Amrita Banerjee
North Dakota State University
40 Papers
69 Citations
Amrita Banerjee is an academic researcher from North Dakota State University. The author has contributed to research in topics: Biology & Chemistry. The author has an hindex of 18, co-authored 29 publications. Previous affiliations of Amrita Banerjee include University of California & Agricultural Research Service.
Chat about Author
Papers
Role of nanoparticle size, shape and surface chemistry in oral drug delivery.
TL;DR: Understanding the role of nanoparticle geometry in intestinal uptake and transport will bring forth a paradigm shift in nanoparticle engineering for oral delivery and non-spherical nanoparticles should be further investigated and considered for Oral delivery of therapeutic drugs and diagnostic materials.
620
Micro- and nanoplastic induced cellular toxicity in mammals: A review
TL;DR: This review discusses the potential routes of exposure to micro- and nanoplastics, biological effects of these particles in mammalian cells, factors influencing toxicity, and the probable mechanisms of cytotoxicity.
345
Ionic liquids for oral insulin delivery.
Amrita Banerjee,Kelly N. Ibsen,Kelly N. Ibsen,Tyler Brown,Renwei Chen,Christian Agatemor,Samir Mitragotri +6 more
TL;DR: The development of a highly effective oral insulin formulation using choline and geranate (CAGE) ionic liquid that significantly enhanced oral insulin absorption by efficiently circumventing the gastrointestinal barriers and demonstrated good stability at room temperature and under refrigeration is reported.
315
Improvement of drug safety by the use of lipid-based nanocarriers
TL;DR: In this article, a lipid-based nanocarrier is used to improve drug safety and efficacy in aqueous media. But, the authors do not consider the effect of surface modification of these nanoccarriers.
296
Shape and size-dependent immune response to antigen-carrying nanoparticles
TL;DR: Evidence is provided for size- and shape-dependent modulation of immune responses and this knowledge can be leveraged to rationally design and develop next generation vaccines against a wide range of pathogens.
273